Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From DiamiR LLC
The exercising by Janssen Biotech of an option to develop OSE Immunotherapeutics’ Phase II-ready antibody fragment for autoimmune and transplant-associated disorders will give an early boost to the French biotech that only completed a merger several weeks ago.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing